Related Experiment Videos
Changing pattern of primary hyperoxaluria in Switzerland
Summary
Primary hyperoxaluria (PH) diagnosis is often delayed, but its prognosis is better than previously thought. Increased awareness of PH is crucial for improving long-term patient outcomes.
Area of Science:
- Nephrology
- Genetics
- Rare Diseases
Background:
- Primary hyperoxaluria (PH) exhibits variable clinical courses and delayed diagnoses.
- Limited data exists on the epidemiology and current prognosis of PH.
Purpose of the Study:
- To determine the occurrence and prognosis of primary hyperoxaluria in Switzerland.
- To analyze diagnostic delays and survival rates in PH patients.
Main Methods:
- Survey of Swiss nephrologists to identify PH patients observed over 15 years.
- Analysis of patient data including diagnosis, treatment, and outcomes.
- Life table analysis to estimate survival and end-stage renal failure rates.
Main Results:
- Prevalence of PH (type 1) estimated at 2 per million population; minimal incidence of 1 per 100,000 live births.
- Median diagnostic delay of 8 years, except in infants. Five patients showed pyridoxine sensitivity.
- By age 25, 50% of patients reached end-stage renal failure, and 20% had died. Prognosis improved over the observation period.
Conclusions:
- The overall prognosis of PH appears more favorable than previously assumed, despite its wide clinical spectrum.
- Enhanced awareness of PH is essential for improving long-term patient outcomes.